The investigators observed that Propranolol, a beta-blocker commonly used in children was
efficient to control the growth of alarming hemangiomas of the face.
The primary objective of this study is to determine the efficiency of 1 month-early treatment
of propranolol in infants aged less than 4 months affected by an hemangioma without any
consequences on vital or functional structure and not justifying corticosteroids.
The secondary objectives are:
- the kinetic of the hemangioma evolution in infants treated by propranolol
- Observance
- Safety